Physician

Penporn Vongsvivut Reck, MD

According to 2025 Medicare claims, Penporn Reck, MD (NPI: 1811919871) practices ophthalmology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is EYE PHYSICIANS OF OLYMPIA INC PS (NPI: 1821165911; TIN: 910872708) and primary practice location at 98503-1014.

Reck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 334 traditional Medicare patients, billed 16,235 HCPCS/CPT codes, and received $814,128 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 183 prescription claims across 37 beneficiaries totaling $19,771 in drug costs, led by Ilevro (Nepafenac). Open Payments data shows 6 records totaling $121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $5,032 to $19,771. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$525K$1.0M2015 Medicare payment: $957,611 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,049,823 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $848,048 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $844,650 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $783,925 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $756,265 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $921,646 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,034,710 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $845,986 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $814,128 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152334,152$957,611
20162254,291$1,049,823
20172063,982$848,048
20182303,148$844,650
20192292,834$783,925
20202253,083$756,265
20212843,569$921,646
20223107,340$1,034,710
202332712,701$845,986
202433416,235$814,128

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$25K2015 Drug cost: $5,032 (USD; Tot_Drug_Cst)2016 Drug cost: $9,432 (USD; Tot_Drug_Cst)2017 Drug cost: $6,138 (USD; Tot_Drug_Cst)2018 Drug cost: $10,846 (USD; Tot_Drug_Cst)2019 Drug cost: $12,174 (USD; Tot_Drug_Cst)2020 Drug cost: $13,930 (USD; Tot_Drug_Cst)2021 Drug cost: $15,808 (USD; Tot_Drug_Cst)2022 Drug cost: $20,729 (USD; Tot_Drug_Cst)2023 Drug cost: $24,792 (USD; Tot_Drug_Cst)2024 Drug cost: $19,771 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151452$5,032
20161688$9,432
20171354$6,138
20181967$10,846
20191274$12,174
20201574$13,930
20212497$15,808
202231173$20,729
202329204$24,792
202437183$19,771

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system264478$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more114240$93
67028Injection of drug into eye131468$83
92134Imaging of retina268732$31
92250Photography of the retina133246$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IlevroNepafenac17574$6,212
Brimonidine TartrateBrimonidine Tartrate311,679$2,011
AcetazolamideAcetazolamide13343$796
Prednisolone AcetatePrednisolone Acetate12538$432
Ketorolac TromethamineKetorolac Tromethamine20666$279

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$121Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Penporn Vongsvivut Reck, MD?

Tedicare shows public-source Medicare data for Penporn Vongsvivut Reck, MD (NPI 1811919871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Penporn Vongsvivut Reck, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Penporn Vongsvivut Reck, MD?

Penporn Vongsvivut Reck, MD is linked to EYE PHYSICIANS OF OLYMPIA INC PS (billing NPI 1821165911) in the available physician profile data.

Does Penporn Vongsvivut Reck, MD have Open Payments data?

Penporn Vongsvivut Reck, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.